Skip to main content
Clinical Trials/CTRI/2017/02/007930
CTRI/2017/02/007930
Completed
未知

STRIDE â?? Study of the effect of Topical waRm oxygen In treatment of Diabetic foot ulcEr - STRIDE

Yostra Labs Private Limited0 sites20 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Yostra Labs Private Limited
Enrollment
20
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 13, 2019
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Yostra Labs Private Limited

Eligibility Criteria

Inclusion Criteria

  • 1\) Subject has a documented diagnosis of Diabetes mellitus â?? Type 1 or type 2
  • 2\) Leg ulcers with duration of more than 6 weeks but no longer than 1 year
  • 3\) Wound type â?? Chronic wound ulcer, Wagner\-Meggit Grade 2, 3
  • 4\) Wound size range: greater than or equal to 25 sq. cm and less than or equal to 150 sq. cm
  • 5\) In case of multiple ulcers, only the largest is considered in the study (index ulcer)
  • 6\) Index ulcer must be greater than or equal to 1 cm away from any other ulcers present on the foot
  • 7\) Adequate perfusion with ABI greater than 0\.7

Exclusion Criteria

  • 1\) Peripheral vascular disease (PVD) \- Arterial disease that is untreated
  • 2\) Evidence of gangrene of any part of the affected limb
  • 3\) Documented evidence of osteomyelitis on any part of affected limb
  • 4\) Index ulcer has exposed bone
  • 5\) Index ulcer exhibits signs of severe clinical infection that requires hospitalization or immediate surgical intervention
  • 6\) Active Charcot foot on the study limb
  • 7\) Uncontrolled diabetes: HbA1c \> 10 %
  • 8\) Renal dialysis or creatinineine \> 2\.0
  • 9\) Active treatment of malignancy (not specific to study limb) and patients on immunosuppresants
  • 10\) Patient has a Deep Vein Thrombosis within the last 30 days

Outcomes

Primary Outcomes

Not specified

Similar Trials